Nyumbani › Melanoma › Florida › Orlando
Majaribio ya kliniki ya Melanoma katika Orlando, FL
Masomo 15 ya Melanoma yanatafuta washiriki katika vituo vya Orlando na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
InaajiriHatua 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · Mi 16 mbali
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
InaajiriHatua 3
- Orlando Health Cancer Institute, Orlando
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
InaajiriHatua 2
- Nemours Children's Hospital, Orlando
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
InaajiriHatua 3
- Orlando Health Cancer Institute, Orlando
- Health Central, Ocoee · Mi 10 mbali
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
InaajiriHatua 1
- AdventHealth, Orlando
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
InaajiriHatua 2
- Orlando Health Cancer Institute, Orlando
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
InaajiriHatua 1
- Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Project: Every Child for Younger Patients With Cancer
InaajiriUtafiti wa uchunguzi
- AdventHealth Orlando, Orlando
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
InaajiriHatua 1/2
- AdventHealth Celebration, Celebration · Mi 17 mbali
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
InaajiriHatua 1/2
- Clermont Oncology Center, Clermont · Mi 24 mbali
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
InaajiriHatua 1
- Florida Cancer Specialists - Lake Nona, Orlando
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
InaajiriHatua 1/2
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
InaajiriHatua 1/2
- Orlando Health Cancer Institute, Orlando
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
InaajiriHatua 3
- Orlando Health Cancer Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
InaajiriHatua 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · Mi 17 mbali
Majaribio ya Melanoma katika miji mingine
- Houston, TXUtafiti 59
- New York City, NYUtafiti 38
- Los Angeles, CAUtafiti 34
- Nashville, TNUtafiti 33
- Pittsburgh, PAUtafiti 31
- Boston, MAUtafiti 26
- Philadelphia, PAUtafiti 23
- San Francisco, CAUtafiti 22
- Durham, NCUtafiti 21
- Atlanta, GAUtafiti 21
- St. Louis, MOUtafiti 21
- Columbus, OHUtafiti 21
Masomo mengine katika Orlando
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 44
- UnenepuUtafiti 31
- Saratani ya MetastasiUtafiti 29
- Uzito Kupita KiasiUtafiti 27
- Ugonjwa wa AlzheimerUtafiti 25
- Kisukari cha Aina ya 2Utafiti 24
- Saratani (aina zote)Utafiti 24
- Saratani ya MatitiUtafiti 23
- Kansari ya MayaiUtafiti 22
- Colitis ya UlcerativeUtafiti 22
- Saratan ya MapafuUtafiti 21
- Kansari ya kolorektaliUtafiti 19
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.